A1. Novel Agents
Poster Session: Novel Agents
Aliaa Fouad, PhD
Infectious Diseases Pharmacotherapy Fellow
Hartford Hospital
Farmington, Connecticut, United States
April M. Bobenchik, PhD
Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
Andrew E. Clark, PhD, D(ABMM)
Assistant Professor
University of Texas Southwestern Medical Center
Dallas, Texas, United States
Lars Westblade, PhD
Clinical Microbiology Laboratory Director/Associate Professor
Weill Cornell Medicine
New York, NY, United States
Holly K. Huse, PhD
Harbor-UCLA Medical Center
Torrance, California, United States
Isabella W. Martin, MD
Medical Director of Microbiology
Dartmouth-Hitchcock Medical Center
Lebanon, NH, United States
A. Brian Mochon, PhD
University of Arizona College of Medicine
Phoenix, Arizona, United States
Erik Munson, PhD
Marquette University
Milwaukee, Wisconsin, United States
Maroun M. Sfeir, MD, MPH, MS
Microbiology Laboratory Director
University of Connecticut Health Center
Farmington, Connecticut, United States
Monica Srodon, MD
Eastern Connecticut Health Network
Manchester, Connecticut, United States
Yungchou Wang, MBA, MLS(ASCP)BB
Cape Regional Health System
Cape May Court House, New Jersey, United States
David P. Nicolau, PharmD
Director
Hartford Hospital
Hartford, Connecticut, United States
Tomefa E. Asempa, PharmD
Associate Director
Hartford Hospital
Hartford, CT, United States